Particle.news

Download on the App Store

Iara Mantiñán Dies Following Experimental Sarcoma Therapy, Heralded for Patient Advocacy

Her death crowns a decade of relentless advocacy that transformed sarcoma patient support and research investment across Spain.

Image
Image
Image

Overview

  • Iara Mantiñán passed away in early July 2025 in Madrid after undergoing an experimental therapy at Hospital Clínico San Carlos.
  • She navigated nearly ten years of living with ultra-rare extraosseous myxoid chondrosarcoma that metastasized to her lungs and brain.
  • As founding president of the Asociación de Sarcomas de Galicia (Asarga) since 2020, she spearheaded publications of patient testimonies and training events to support sarcoma sufferers.
  • She highlighted obstacles in Spain’s decentralized health system that complicate clinical trials, unified patient records and access to treatments for rare cancer patients.
  • Her family and Asarga commemorated her legacy of dogged patient advocacy and urged continued investment in research for ultra-rare cancers.